News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 644
- Sources here
- 15
- Companies here
- 20
Active search
644 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Reaffirming 2026 Outlook And Highlighting Mobi Momentum
Tandem Diabetes Care (TNDM) saw its stock rise 14.8% after reaffirming its full-year 2026 sales outlook of US$1.07–1.09 billion and highlighting early success with its Pay-As-You-Go pharmacy model and growing adoption of its Mobi platform. The company reported second-quarter sales of US$254.56 million and …
Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Record Q2 Sales And PayGo Momentum
Tandem Diabetes Care (TNDM) saw its stock rise 14.8% after reporting record Q2 2026 worldwide sales of US$254.56 million, a higher gross margin, and a reduced net loss, while reaffirming its full-year sales guidance of US$1.07 billion. The company's new PayGo pharmacy model, which …
Tandem Diabetes Care (TNDM) Could Be 23% Below Fair Value After Q2 Results
Tandem Diabetes Care (TNDM) reported strong Q2 2026 results with record worldwide sales and reaffirmed full-year guidance, leading to a significant rally in its share price. Despite the recent gains, Simply Wall St. suggests that TNDM is still undervalued by 23.4%, with a fair …
The Andersons, Inc. Reports Second Quarter Results
The Andersons, Inc. (Nasdaq: ANDE) reported strong second-quarter 2026 financial results, with net income attributable to the company of $57 million ($1.65 per diluted share) and adjusted net income of $74 million ($2.15 per diluted share). The Renewables segment achieved record pretax income of …
Banco Santander (BME:SAN) Wins Webster Approval, Is The Stock Fully Valued?
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Regulatory approval for Webster deal puts Banco Santander in focus Banco Santander (BME:SAN) is back on investors' radar after securing US Federal Reserve approval …
Santander, Berkshire Hathaway among gainers; HSBC, Sezzle in losers: week's financials wrap
[Old Fashioned Bank Sign] georgeclerk/E+ via Getty Images Wall Street finished the week higher [https://seekingalpha.com/article/4933719-what-moved-markets-this-week], with the benchmark S&P 500 hitting fresh all-time highs as investors digested key earnings from technology giants alongside the latest payrolls data. A sharp contraction in the U.S. labor …
Banco Santander Nears Completion of Multi-Billion-Euro Share Buyback
Banco Santander is nearing the completion of a substantial share buyback program, having repurchased approximately €4.39 billion worth of shares, representing 87.3% of the planned maximum investment. Since 2021, the bank has bought back around 17.7% of its outstanding shares, aiming to reduce share …
Sharemaestro market context Trend signal active 52 weeks +77.6% · Next-week setup positive 66.4%Sei Investments Co. Acquires 59,693 Shares of Andersen Group Inc. $ANDG
Sei Investments Co. significantly increased its stake in Andersen Group Inc. by 96.3% in the first quarter, acquiring 59,693 additional shares to reach a total of 121,649 shares valued at approximately $3.31 million. Despite a recent earnings miss where Andersen Group reported $0.03 EPS …
Wall Street Zen Upgrades Candel Therapeutics (NASDAQ:CADL) to "Hold"
Wall Street Zen has upgraded Candel Therapeutics (NASDAQ:CADL) from a "Sell" to a "Hold" rating. This follows a similar upgrade by Zacks Research to "Hold." The company is developing oncolytic viral therapies for solid tumors, and its shares opened at $10.59, near its 52-week …
Andersons (NASDAQ:ANDE) Rating Increased to Strong-Buy at Wall Street Zen
Wall Street Zen has upgraded Andersons (NASDAQ:ANDE) to a "strong-buy" rating from "buy." This comes as Andersons reported quarterly EPS of $2.15, exceeding estimates, despite revenue falling slightly short of expectations. The stock opened at $65.39, down 3.8%, with a market capitalization of approximately …
Tandem Diabetes Care (TNDM) Stock Jumps As Margin Recovery Steals The Spotlight
Tandem Diabetes Care's stock surged 19% after its Q2 earnings report, despite a net loss, due to a significant recovery in gross margin to 57%. Revenue grew 6%, and the net loss narrowed by 60%, with strong performance in international pump shipments and an …
Standex (SXI) Q4 2026 Earnings Call Transcript
Standex (SXI) reported record Q4 2026 earnings, with net sales growing 7.7% organically to $228.3 million and adjusted EPS reaching $2.45. The company is strategically focusing on expanding its grid business capacity, aiming for $340 million to $440 million in annual sales by fiscal …
Tandem Diabetes Care, Inc. Stock 12‑Month Price Target Raised to $29.5, Implies 57% Upside
Analysts have raised the average 12-month price target for Tandem Diabetes Care, Inc. (TNDM) stock to $29.5, up from $29.19. This new target suggests a potential upside of approximately 57% from its August 6th closing price. The consensus rating among 22 analysts remains a …
SANB11: Upcoming Governance Shakeup Will Support Bullish Long-Term Outlook
Banco Santander (Brasil) (SANB11) has seen its analyst price target adjusted to R$34.43, reflecting updated assumptions for revenue, profit margins, and P/E multiple. The company is undergoing significant governance changes, including a proposed acquisition by Banco Santander, S.A., a CEO transition, and an upcoming …
Banco Santander (BME:SAN) Stock May Be 31% Undervalued On Fed Deal Approval
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Banco Santander has delivered very strong gains for shareholders over the last five years, …
Tandem Diabetes Care Announces Second Quarter 2026 Financial Results
Tandem Diabetes Care, Inc. reported strong financial results for Q2 2026, with worldwide sales increasing 6% to $254.6 million and gross margin up 460 basis points to 57%. The company also highlighted strategic achievements, including FDA submissions for Tandem Mobi, expanded global technology solutions, …
Tandem Diabetes Care Inc (TNDM) News, Articles, Events & Latest Updates
Tandem Diabetes Care Inc (TNDM) reported Q2 2026 financial results, including a loss and lagging revenue estimates, despite some key metrics showing positive movement. The company announced upcoming conference presentations, product compatibility expansions, and plans to release Q2 results in August 2026. This news …
Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TNDM)
Tandem Diabetes Care, Inc. published its Q2 2026 earnings call presentation, reporting an EPS of -$0.31, which beat estimates by $0.01. The company's revenue for the quarter was $254.56M, representing a 5.77% year-over-year increase, though it missed revenue expectations by $510.18K. The slide deck …
Standex International Corp (SXI) Shares Surge 3.4% -- What GF Sc
Standex International Corp (SXI) shares rose 3.4% to $337.63. GuruFocus indicates the stock is significantly overvalued by 53.1% based on its GF Value™ estimate of $220.55. The company has a GF Score™ of 68/100, showing strong profitability but lower growth and valuation ranks, and …
Santander Gets Fed Approval for Webster Acquisition
Santander has received approval from the Federal Reserve for its acquisition of Webster Financial Corporation, following earlier approvals from the OCC and ECB. The transaction is expected to close on August 20, 2026, and will merge Webster's operations into Santander Bank, N.A., aiming to …
KBDC Q2'26 Earnings: EPS estimate is 0.40 USD
Kayne Anderson BDC, Inc. (KBDC) is scheduled to release its Q2'26 earnings on August 10, after market close, with an estimated EPS of $0.40 and revenue of $51.86 million. The article provides a table comparing reported and estimated revenues and EPS for recent quarters, …
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Down - What's Next?
Tandem Diabetes Care (NASDAQ:TNDM) shares gapped down but later rose by 13.8%. Analyst ratings are mixed, with a consensus "Hold" and an average price target of $28.77, though Mizuho lowered its target to $20. The company reported an adjusted loss of $0.31 per share, …